MicroRNAs and their target gene networks in renal cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 405, Issue 2, 2011, Pages 153-156

  Redova, Martina ^a   Svoboda, Marek ^a   Slaby, Ondrej ^a,b  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Epithelial mesenchymal transition; Hypoxia; MicroRNA; Proliferation; Renal cell carcinoma

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; MICRORNA;

ANGIOGENESIS; APOPTOSIS; CANCER INVASION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUNCTION; GENE TARGETING; HUMAN; KIDNEY CARCINOMA; METASTASIS; PRIORITY JOURNAL; SHORT SURVEY;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL HYPOXIA; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 79651472671     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.019     Document Type: Short Survey

References (52)

1. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., Sevignani C., Byrne D., Negrini M., Pagano F., Gomella L.G., Croce C.M., Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 2007, 25:387-392.
2. White N.M.A., Yousef G.M. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. BMC Med. 2010, 8:65.
3. van Spronsen D.J., Mulders P.F., de Mulder P.H. Novel treatments for metastatic renal cell carcinoma. Crit. Rev. Oncol. Hematol. 2005, 55:177-191.
4. Campbell S.C., Novick A.C., Bukowski R.M. Renal tumors. Campbell-Wals Urology, ninth edn. 2007, 1567-1637. Saunders, Philadelphia, PA. A.J. Wein, L.R. Kavoussi, A.C. Novick, A.W. Partin, C.A. Peters (Eds.).
5. Yi Z., Fu Y., Zhao S., Zhang X., Ma Ch. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J. Cancer. Res. Clin. Oncol. 2010, 136:855-862.
6. Huang Y., Dai Y., Yang J., Chen T., Yin Y., Tang M., Hu C., Zhang L. Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur. J. Surg. Oncol. 2009, 35:1119-1123.
7. Janzen N.K., Kim H.L., Figlin R.A., Belldegrun A.S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North. Am. 2003, 30:843-852.
8. Escudier B. Advanced renal cell carcinoma: current and emerging management strategies. Drugs 2007, 67:1257-1264.
9. Chow T.F., Youssef Y.M., Lianidou E., Romaschin A.D., Honey R.J., Stewart R., Pace K.T., Yousef G.M. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 2010, 43:150-158.
10. Garzon R., Pichiorri F., Palumbo T., Visentini M., Aqeilan R., Cimmino A., Wang H., Sun H., Volinia S., Alder H., Calin G.A., Liu C.G., Andreeff M., Croce C.M. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007, 26:4148-4157.
11. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 2006, 6:857-866.
12. Slaby O., Jancovicova J., Lakomy R., Svoboda M., Poprach A., Fabian P., Kren L., Michalek J., Vyzula R. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J. Exp. Clin. Cancer. Res. 2010, 29:90.
13. Mulero-Navarro S., Esteller M. Epigenetic biomarkers for human cancer: the time is now. Crit. Rev. Oncol. Hematol. 2008, 68:1-11.
14. Hummel R., Hussey D.J., Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur. J. Cancer. 2010, 46:298-311.
15. Abbott A.L., Alvarez-Saavedra E., Miska E.A., Lau N.C., Bartel D.P., Horvitz H.R., Ambros V. The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev. Cell. 2005, 9:403-414.
16. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
17. Liu H., Brannon A.R., Reddy A.R., Alexe G., Seiler M.W., Arreola A., Oza J.H., Yao M., Juan D., Liou L.S., Ganesan S., Levine A.J., Rathmell W.K., Bhanot G.V. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst. Biol. 2010, 4:51.
18. Ambs S., Prueitt R.L., Yi M., Hudson R.S., Howe T.M., Petrocca F., Wallace T.A., Liu C.G., Volinia S., Calin G.A., Yfantis H.G., Stephens R.M., Croce C.M. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008, 68:6162-6170.
19. J.D. Roybal, Y. Zang, Y.H. Ahn, Y. Yang, D.L. Gibbons, B.N. Baird, C.A. Alvarez, N. Thilaganathan, P. Saintigny, D. Liu, J.V. Heymach, C.J. Creighton, J.M. Kurie, MiR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1, Mol. Cancer. Res. (2010) [in press]. doi:10.1158/1541-7786.MCR-10-0497. doi:10.1158/1541-7786.MCR-10-0497.
20. Ma L. Role of miR-10b in breast cancer metastasis. Breast Cancer. Res. 2010, 12:210.
21. Slaby O., Svoboda M., Michalek J., Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol. Cancer. 2009, 8:102.
22. Lin J., Horikawa Y., Tamboli P., Clague J., Wood C.G., Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010, 31:1805-1812.
23. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 2005, 353:1768-1771.
24. Juan D., Alexe G., Antes T., Liu H., Madabhushi A., Delisi C., Ganesan S., Bhanot G., Liou L.S. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010, 75:835-841.
25. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., Davuluri R., Liu C.G., Croce C.M., Negrini M., Calin G.A., Ivan M. A microRNA Signature of hypoxia. Mol. Cell. Biol. 2007, 27:1859-1867.
26. Chen Z., Li Y., Zhang H., Huang P., Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29:4362-4368.
27. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., Li C., O'Brien-Jenkins A., Katsaros D., Weber B.L., Simon C., Coukos G., Zhang L. MiR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 2008, 7:255-264.
28. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer. 2007, 6:60.
29. Gonsalves C.S., Kalra V.K. Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p. J. Immunol. 2010, 184:3878-3888.
30. Muth M., Theophile K., Hussein K., Jacobi C., Kreipe H., Bock O. Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression. J. Transl. Med. 2010, 8:33.
31. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB. J. Biol. Chem. 2008, 283:14910-14914.
32. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes. Dev. 2008, 22:894-907.
33. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
34. Gibbons D.L., Lin W., Creighton C.J., Rizvi Z.H., Gregory P.A., Goodall G.J., Thilaganathan N., Du L., Zhang Y., Pertsemlidis A., Kurie J.M. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes. Dev. 2009, 23:2140-2151.
35. Bindels S., Mestdagt M., Vandewalle C., Jacobs N., Volders L., Noël A., van Roy F., Berx G., Foidart J.M., Gilles C. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006, 25:4975-49875.
36. Pantuck A.J., Seligson D.B., Klatte T., Yu H., Leppert J.T., Moore L., O'Toole T., Gibbons J., Belldegrun A.S., Figlin R.A. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer 2007, 109:2257-2267.
37. Rathmell W.K., Chen S. VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment. Expert. Rev. Anticancer. Ther. 2008, 8:63-73.
38. Dromard M., Bompard G., Glondu-Lassis M., Puech C., Chalbos D., Freiss G. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation. Cancer Res. 2007, 67:6806-6813.
39. Felipe A., Vicente R., Villalonga N., Roura-Ferrer M., Martínez-Mármol R., Solé L., Ferreres J.C., Condom E. Potassium channels: new targets in cancer therapy. Cancer Detect. Prev. 2006, 30:375-385.
40. Wong C.F., Tellam R.L. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J. Biol. Chem. 2008, 283:9836-9843.
41. Jung M., Mollenkopf H.J., Grimm C., Wagner I., Albrecht M., Waller T., Pilarsky C., Johannsen M., Stephan C., Lehrach H., Nietfeld W., Rudel T., Jung K., Kristiansen G. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J. Cell. Mol. Med. 2009, 13:3918-3928.
42. Tsang W.P., Kwok T.T. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 2010, 21:140-146.
43. Kaddar T., Rouault J.P., Chien W.W., Chebel A., Gadoux M., Salles G., Ffrench M., Magaud J.P. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol. Cell. 2009, 101:511-524.
44. Dutta K.K., Zhong Y., Liu Y.T., Yamada T., Akatsuka S., Hu Q., Yoshihara M., Ohara H., Takehashi M., Shinohara T., Masutani H., Onuki J., Toyokuni S. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci. 2007, 98:1845-1852.
45. Gumz M.L., Zou H., Kreinest P.A., Childs A.C., Belmonte L.S., LeGrand S.N., Wu K.J., Luxon B.A., Sinha M., Parker A.S., Sun L.Z., Ahlquist D.A., Wood C.G., Copland J.A. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin. Cancer Res. 2007, 13:4740-4749.
46. Bandres E., Bitarte N., Arias F., Agorreta J., Fortes P., Agirre X., Zarate R., Diaz-Gonzalez J.A., Ramirez N., Sola J.J., Jimenez P., Rodriguez J., Garcia-Foncillas J. MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res. 2009, 15:2281-2290.
47. Nakada C., Matsuura K., Tsukamoto Y., Tanigawa M., Yoshimoto T., Narimatsu T., Nguyen L.T., Hijiya N., Uchida T., Sato F., Mimata H., Seto M., Moriyama M. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J. Pathol. 2008, 216:418-427.
48. le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafrè S.A., Farace M.G., Agami R. Regulation of the p27 (Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007, 26:3699-3708.
49. Chu I.M., Hengst L., Slingerland J.M. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 2008, 8:253-267.
50. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., Chen C.J., Hildesheim A., Sugden B., Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. USA 2008, 105:5874-5878.
51. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell. Res. 2008, 18:350-359.
52. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.